Journal
NEUROSCIENCE LETTERS
Volume 436, Issue 3, Pages 326-330Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2008.03.051
Keywords
anti-apoptotic proteins; BCI-X(L); XIAP; AAV-vectors; quinolinic acid; neuroprotection; motor function; striatum
Categories
Ask authors/readers for more resources
Apoptotic mechanisms have been proposed to contribute to the selective loss of medium spiny striatal projection neurons in Huntington's disease (HD). This raises the question as to whether enhancing the expression of anti-apoptotic factors in vulnerable striatal projection neurons can reduce their susceptibility to neurotoxic processes occurring in the HD brain. In this study AAV(1/2) vectors encoding either the anti-apoptotic factor BCI-X(L) or XIAP were used to transduce striatal neurons prior to an intrastriatal injection of the excitotoxic glutamate analogue quinolinic acid (QA). AAV(1/2) vector treated rats were observed in behavioural tests undertaken to assess whether anti-apoptotic factor expression provided amelioration of motor function impairment following unilateral QA-induced striatal lesioning. AAV-XIAP treated rats displayed complete amelioration of an ipsilateral forelimb use bias relative to control animals. However, neither AAV-XIAP nor AAV-Bcl-X(L) treated rats demonstrated an improvement in sensorimotor neglect compared to control animals. Furthermore, we did not observe a significant reduction of QA-induced pathology in assessed neuronal populations of the basal ganglia. These results indicate that sole enhancement of XIAP or Bcl-X(L) is not sufficient to counteract QA-induced excitotoxic insult of striatal neurons. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available